UNLOCKING THE POWER OF EXOSOMES
Exosomes are tiny vesicles that ferry biomolecules like proteins and nucleic acids between cells. With properties inherited from their source cells, these versatile vesicles offer a safer, lower-cost, and higher-quality alternative to regenerative stem cell therapies. They can be enriched with compounds of interest, holding great promise as a new method for targeted drug delivery. Through strategic partnerships, ConvEyXO is leading the way in developing technologies to unlock the full therapeutic potential of exosomes at an affordable cost.

ABUNDANT APPLICATIONS
Exosomes play a key role in cell-to-cell communication and can modulate the behavior of nearby and distant cells.
Exosomes secreted from mesenchymal stem cells retain the immunomodulatory and anti-inflammatory properties of their source cells and present a promising alternative to cell therapies in regenerative medicine.
But potential applications of exosomes are many, as the vesicles can be loaded with molecules that amplify or change their activity, such as RNA, proteins, or any water-soluble drug compound.
Preclinical results confirm the potential of loaded exosomes in neurodegenerative, cardiovascular, musculoskeletal, auto immune, and infectious diseases, as well as oncology.
Both natural and loaded exosomes can be altered to precisely target specific cells or tissues by attaching ligands to their surface. The exosomes are then directed to the cells of interest to deliver the loaded compound. This reduces the dose of the compound and increases its potency on the targeted cells only.
The application of loading and/or targeting technology results in engineered exosomes.
UNIQUE BENEFITS
There are several unique benefits offered by both the inherent properties of exosomes and those obtained by engineering:
LEADING THE WAY FOR EXOSOME-BASED THERAPIES
Together with our strategic partners, we are working to make therapeutic exosomes accessible in a cost-effective way. Their full potential will be unlocked by tackling the main technical challenges:
Would you like to learn more about our platform, or are you interested in collaborating? Get in touch!